famotidine has been researched along with Dermatitis, Exfoliative in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of agranulocytosis associated with initiation of famotidine." | 7.71 | Agranulocytosis associated with initiation of famotidine therapy. ( Bits, H; Clarfield, AM; Da'as, N; Darmon, D; Kleinman, Y; Marcus, EL, 2002) |
| "To report a case of agranulocytosis associated with initiation of famotidine." | 3.71 | Agranulocytosis associated with initiation of famotidine therapy. ( Bits, H; Clarfield, AM; Da'as, N; Darmon, D; Kleinman, Y; Marcus, EL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcus, EL | 1 |
| Clarfield, AM | 1 |
| Kleinman, Y | 1 |
| Bits, H | 1 |
| Darmon, D | 1 |
| Da'as, N | 1 |
1 other study available for famotidine and Dermatitis, Exfoliative
| Article | Year |
|---|---|
Agranulocytosis associated with initiation of famotidine therapy.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Blood Cell Count; Dermatitis, Exfoliative; Famotidine; Hum | 2002 |